vs
Enact Holdings, Inc.(ACT)与P3 Health Partners Inc.(PIII)财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是Enact Holdings, Inc.的1.2倍($384.8M vs $312.7M),P3 Health Partners Inc.同比增速更快(3.8% vs 3.6%),过去两年Enact Holdings, Inc.的营收复合增速更高(3.6% vs -0.5%)
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商,为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案,帮助首付较低的购房者获得可负担的住房贷款,助力更多美国普通消费者实现安居需求。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业,与基层医疗机构及医疗系统合作,为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务,致力于提升诊疗效果、降低不必要的医疗开支。
ACT vs PIII — 直观对比
营收规模更大
PIII
是对方的1.2倍
$312.7M
营收增速更快
PIII
高出0.2%
3.6%
两年增速更快
ACT
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $312.7M | $384.8M |
| 净利润 | — | $-75.5M |
| 毛利率 | — | — |
| 营业利润率 | 71.3% | -40.0% |
| 净利率 | — | -19.6% |
| 营收同比 | 3.6% | 3.8% |
| 净利润同比 | — | -28.8% |
| 每股收益(稀释后) | $1.23 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACT
PIII
| Q4 25 | $312.7M | $384.8M | ||
| Q3 25 | $311.5M | $345.3M | ||
| Q2 25 | $304.9M | $355.8M | ||
| Q1 25 | $306.8M | $373.2M | ||
| Q4 24 | $301.8M | $370.7M | ||
| Q3 24 | $309.6M | $362.1M | ||
| Q2 24 | $298.8M | $379.2M | ||
| Q1 24 | $291.6M | $388.5M |
净利润
ACT
PIII
| Q4 25 | — | $-75.5M | ||
| Q3 25 | — | $-31.6M | ||
| Q2 25 | — | $-20.4M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | $-58.6M | ||
| Q3 24 | — | $-46.5M | ||
| Q2 24 | — | $-12.0M | ||
| Q1 24 | — | $-18.7M |
营业利润率
ACT
PIII
| Q4 25 | 71.3% | -40.0% | ||
| Q3 25 | 67.4% | -12.8% | ||
| Q2 25 | 70.4% | -9.6% | ||
| Q1 25 | 68.9% | -10.2% | ||
| Q4 24 | 68.9% | -37.4% | ||
| Q3 24 | 74.1% | -29.5% | ||
| Q2 24 | 78.6% | -8.3% | ||
| Q1 24 | 70.6% | -11.3% |
净利率
ACT
PIII
| Q4 25 | — | -19.6% | ||
| Q3 25 | — | -9.1% | ||
| Q2 25 | — | -5.7% | ||
| Q1 25 | — | -5.5% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | — | -3.2% | ||
| Q1 24 | — | -4.8% |
每股收益(稀释后)
ACT
PIII
| Q4 25 | $1.23 | $-23.08 | ||
| Q3 25 | $1.10 | $-9.67 | ||
| Q2 25 | $1.11 | $-6.23 | ||
| Q1 25 | $1.08 | $-6.28 | ||
| Q4 24 | $1.05 | $-23.13 | ||
| Q3 24 | $1.15 | $-15.70 | ||
| Q2 24 | $1.16 | $-7.37 | ||
| Q1 24 | $1.01 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $25.0M |
| 总债务越低越好 | $744.5M | $228.4M |
| 股东权益账面价值 | $5.4B | $-155.2M |
| 总资产 | $6.9B | $656.6M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACT
PIII
| Q4 25 | $582.5M | $25.0M | ||
| Q3 25 | $545.6M | $37.7M | ||
| Q2 25 | $616.0M | $38.6M | ||
| Q1 25 | $639.0M | $40.1M | ||
| Q4 24 | $602.8M | $38.8M | ||
| Q3 24 | $674.9M | $63.0M | ||
| Q2 24 | $711.3M | $73.1M | ||
| Q1 24 | $624.3M | $27.3M |
总债务
ACT
PIII
| Q4 25 | $744.5M | $228.4M | ||
| Q3 25 | $744.1M | $252.8M | ||
| Q2 25 | $743.8M | $182.0M | ||
| Q1 25 | $743.4M | $171.1M | ||
| Q4 24 | $743.0M | $108.9M | ||
| Q3 24 | $742.7M | $133.2M | ||
| Q2 24 | $742.4M | $133.1M | ||
| Q1 24 | $746.1M | $118.1M |
股东权益
ACT
PIII
| Q4 25 | $5.4B | $-155.2M | ||
| Q3 25 | $5.3B | $-18.7M | ||
| Q2 25 | $5.2B | $44.5M | ||
| Q1 25 | $5.1B | $63.3M | ||
| Q4 24 | $5.0B | $75.9M | ||
| Q3 24 | $5.0B | $120.5M | ||
| Q2 24 | $4.8B | $166.8M | ||
| Q1 24 | $4.7B | $146.6M |
总资产
ACT
PIII
| Q4 25 | $6.9B | $656.6M | ||
| Q3 25 | $6.9B | $683.6M | ||
| Q2 25 | $6.8B | $731.6M | ||
| Q1 25 | $6.7B | $783.9M | ||
| Q4 24 | $6.5B | $783.4M | ||
| Q3 24 | $6.6B | $833.3M | ||
| Q2 24 | $6.3B | $892.8M | ||
| Q1 24 | $6.3B | $855.9M |
负债/权益比
ACT
PIII
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | 4.09× | ||
| Q1 25 | 0.15× | 2.71× | ||
| Q4 24 | 0.15× | 1.43× | ||
| Q3 24 | 0.15× | 1.11× | ||
| Q2 24 | 0.15× | 0.80× | ||
| Q1 24 | 0.16× | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $724.5M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ACT
PIII
| Q4 25 | $724.5M | $-25.7M | ||
| Q3 25 | $192.0M | $-15.4M | ||
| Q2 25 | $119.5M | $-16.6M | ||
| Q1 25 | $226.7M | $-33.5M | ||
| Q4 24 | $686.3M | $-57.2M | ||
| Q3 24 | $188.1M | $-22.6M | ||
| Q2 24 | $144.7M | $-10.2M | ||
| Q1 24 | $187.3M | $-20.0M |
资本支出强度
ACT
PIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
暂无分部数据
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |